Literature DB >> 1578903

Horseradish peroxidase retention and washout in blood-brain barrier lesions.

P A Stewart1, C R Farrell, C L Farrell, E Hayakawa.   

Abstract

Horseradish peroxidase (HRP) is widely used to visualize blood-brain barrier (BBB) breakdown. In addition to its visual properties, HRP activity can be measured and can, therefore, be used to quantitate barrier leakage rapidly and simply. In addition, the same tissue can be used for electron microscopic studies in which the structural basis for the leakage can be resolved. Here we describe two methods for quantitation of barrier damage using HRP: one in small, multifocal barrier lesions caused by ethanol combined with barbiturates, and a second in large, single-focus, necrotic lesions. We determined the optimal circulation times and fixation methods for each. In the case of multifocal barrier damage, short-term HRP circulation for up to 1 min precisely marked individual leaking vascular segments, which could then be counted and their density calculated. Immersion fixation was necessary since perfusion fixation washed the extravasated HRP out of the tissue. In freeze-lesions, circulation times of at least 5 min were necessary to deliver acceptable amounts of HRP to the tissue. Tissue retention increased with longer circulation times to an optimum of 30 min, but then fell. Perfusion fixation for times as long as 1 h did not affect the tissue retention of HRP.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1578903     DOI: 10.1016/0165-0270(92)90125-w

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  10 in total

Review 1.  Endothelial vesicles in the blood-brain barrier: are they related to permeability?

Authors:  P A Stewart
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

2.  Breakdown of the blood-retinal barrier induced by activated T cells of nonneural specificity.

Authors:  P Hu; J D Pollard; T Chan-Ling
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

3.  Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier.

Authors:  Caroline Charlier; Fabrice Chrétien; Marielle Baudrimont; Elodie Mordelet; Olivier Lortholary; Françoise Dromer
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

4.  Modulation of doxorubicin concentration by cyclosporin A in brain and testicular barrier tissues expressing P-glycoprotein in rats.

Authors:  C S Hughes; S L Vaden; C A Manaugh; G S Price; L C Hudson
Journal:  J Neurooncol       Date:  1998-03       Impact factor: 4.130

5.  Sex-Dependent Macromolecule and Nanoparticle Delivery in Experimental Brain Injury.

Authors:  Vimala N Bharadwaj; Connor Copeland; Ethan Mathew; Jason Newbern; Trent R Anderson; Jonathan Lifshitz; Vikram D Kodibagkar; Sarah E Stabenfeldt
Journal:  Tissue Eng Part A       Date:  2020-07       Impact factor: 3.845

6.  The use of intracerebral microdialysis to determine changes in blood-brain barrier transport characteristics.

Authors:  E C de Lange; M B Hesselink; M Danhof; A G de Boer; D D Breimer
Journal:  Pharm Res       Date:  1995-01       Impact factor: 4.200

7.  The First Postlesion Minutes: An In Vivo Study of Extravasation and Perivascular Astrocytes Following Cerebral Lesions in Various Experimental Mouse Models.

Authors:  László Tóth; Dávid Szöllősi; Katalin Kis-Petik; István Adorján; Ferenc Erdélyi; Mihály Kálmán
Journal:  J Histochem Cytochem       Date:  2018-07-26       Impact factor: 2.479

8.  A peptide for targeted, systemic delivery of imaging and therapeutic compounds into acute brain injuries.

Authors:  Aman P Mann; Pablo Scodeller; Sazid Hussain; Jinmyoung Joo; Ester Kwon; Gary B Braun; Tarmo Mölder; Zhi-Gang She; Venkata Ramana Kotamraju; Barbara Ranscht; Stan Krajewski; Tambet Teesalu; Sangeeta Bhatia; Michael J Sailor; Erkki Ruoslahti
Journal:  Nat Commun       Date:  2016-06-28       Impact factor: 14.919

9.  Clostridium perfringens epsilon toxin induces blood brain barrier permeability via caveolae-dependent transcytosis and requires expression of MAL.

Authors:  Jennifer R Linden; Claudia Flores; Eric F Schmidt; Francisco A Uzal; Adam O Michel; Marissa Valenzuela; Sebastian Dobrow; Timothy Vartanian
Journal:  PLoS Pathog       Date:  2019-11-08       Impact factor: 6.823

10.  A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease.

Authors:  Thérèse Couderc; Fabrice Chrétien; Clémentine Schilte; Olivier Disson; Madly Brigitte; Florence Guivel-Benhassine; Yasmina Touret; Georges Barau; Nadège Cayet; Isabelle Schuffenecker; Philippe Desprès; Fernando Arenzana-Seisdedos; Alain Michault; Matthew L Albert; Marc Lecuit
Journal:  PLoS Pathog       Date:  2008-02-08       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.